Company page
Engene Therapeutics Inc.
Engene Therapeutics Inc. is a public company traded under the ticker ENGN in the American market. With a market capitalization of approximately $115.2 million, the company focuses on developing innovative therapeutics. Engene is dedicated to advancing its pipeline of drug candidates to address unmet medical needs.
- Ticker
- ENGN:NASDAQ
- Asset type
- Stock
- Market cap
- $115.2M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NASDAQ
- Currency
- USD